In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis

Revista Iberoamericana de Micologia

Volumn 22, Issue 2, 2005, Pages 110-113

  Carrillo Muñoz, Alfonso Javier ^a   Cárdenes, Carmen Delia ^a   Carrillo Orive, Bartolomé ^a   Rodríguez, Virginia ^b   Del Valle, Oscar ^b   Bou Casals, José ^c   Ezkurra, Pilar Ariadna ^e   Quindós, Guillermo ^d  

^a Associacio Catalana d'Intelligencia Artificial   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Rosco Diagnostica   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e NONE

Author keywords

Dermatophytes; Fluconazole; Itraconazole; Neosensitabs; Scopulariopsis brevicaulis; Voriconazole

Indexed keywords

AMPICILLIN; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; DERMATOMYCOSIS; DERMATOPHYTE; DRUG SENSITIVITY; EPIDERMOPHYTON; IN VITRO STUDY; INCUBATION TIME; MICROSPORUM; MYCOSIS; NONHUMAN; PAECILOMYCES; SCOPULARIOPSIS BREVICAULIS; TEMPERATURE; TRICHOPHYTON; ANTIBIOTIC RESISTANCE; ARTHRODERMA; ASCOMYCETES; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ARTHRODERMATACEAE; SCOPULARIOPSIS; SCOPULARIOPSIS BREVICAULIS;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; ASCOMYCOTA; DERMATOMYCOSES; DRUG RESISTANCE, FUNGAL; DRUG RESISTANCE, MULTIPLE, FUNGAL; FLUCONAZOLE; HUMANS; ITRACONAZOLE; PYRIMIDINES; TRIAZOLES;

EID: 23144440608     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(05)70019-X     Document Type: Article

References (32)

1. Aguilar C, Pujol I, Guarro J. In vitro antifungal susceptibilities of Scopulariopsis isolates. Antimicrob Agents Chemother 1999; 43: 1520-1522.
2. Bailey EM, Krakovsky DJ, Rybak MJ. The triazole antifungal agents: a review of itraconazole and fluconazole. Pharmacotherapy 1990; 10: 146-153.
3. Bell-Syer SEM, Hart R, Crawford F, Torgerson DJ, Young F, Tyrrel W, Williams H, Russell I. A systematic review of oral treatment for fungal infections of the skin of the feet. J Dermatol Treat 2001; 12: 69-74.
4. Berger AR. Common superficial fungal infections in patient with AIDS. Clin Infect Dis 1996; 22: 128-132.
5. Ghannoum MA, Kuhn DM. Voriconazole - better chances for patients with invasive mycoses. Eur J Med Res 2002; 7: 242-56.
6. Gupta AK. Onychomycoses in the elderly. Drugs Aging 2000; 16: 397-407.
7. Cabañes FJ, Abarca L, Bragulat M, Bruguera T. Sensitivity of some strains of the genus Epidermophyton to different antifungal agents. Mycopathologia 1989; 105: 153-156.
8. Carrillo-Muñoz AJ, Abarca L, Quindós G, Arévalo MP, Bornay-Llinares F, Cabañes FJ, Casals JB, Estivill D, González-Lama Z, Iglesias I, Hernández-Molina JM, Linares MJ, Martín-Mazuelos E, Payá MJ, San Millán R, Rubio MC. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing. Rev Iberom Micol 1999; 16: 97-101.
9. Carrillo-Muñoz AJ, Brió S, Alonso R, del Valle O, Santos P, Quindós G. Ciclopiroxolamine: in vitro antifungal activity against clinical yeasts isolates. Int J Antimicrob Agents 2002; 20: 375-379.
10. Carrillo-Muñoz AJ, Brió S, Quindós G, Palacín C, Guglietta A, Espinel-Ingroff A. Sertaconazole: in vitro antifungal activity against vaginal and other superficial yeasts isolates. J Chemother 2001; 13: 555-562.
11. Carrillo-Muñoz AJ, Fernández-Torres B, Cárdenes DC, Guarro J. In vitro activity of sertaconazole against dermatophyte moulds isolates with reduced fluconazole susceptibility. Chemotherapy 2003; 49: 248-251.
12. Carrillo-Muñoz AJ, Fernández-Torres B, Guarro J. In vitro activity of sertaconazole against 309 strains of dermatophyte moulds. J Chemother 2003; 15: 555-557.
13. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrob Agents Chemother 2003; 47: 2339-2341.
14. Del Palacio A, Garau M, González-Escalada A, Calvo MT. Trends in the treatment of dermatophytosis. In: Kushwaha RKS, Guarro J (Eds.) Biology of dermatophytes and other keratinophilic fungi. Bilbao, Revista Iberoamericana de Micología, 2000: 148-158.
15. Espinel-Ingroff A. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 1998; 36: 198-202.
16. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 2001; 150: 101-115.
17. Fernández-Torres B, Cabañes FJ, Abarca L, Carrillo-Muñoz AJ, Inza I, Guarro J. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999-4003.
18. Fernández-Torres B, Carrillo-Muñoz AJ, Martín E, del Palacio A, Moore M, Valyerde A, Serrano M, Guarro J. In vitro activities of 10 antifungal drugs against 508 dermatophyte isolates. Antimicrob Agents Chemother 2001; 45: 2524-2528.
19. Fernández-Torres B, Carrillo-Muñoz AJ, Ortoneda M, Pujol I, Pastor J, Guarro J. Interlaboratory evaluation of the E-test® for antifungal susceptibility testing. Med Mycol 2003; 41: 125-130.
20. Fernández-Torres B, Vázquez-Veiga H, Llovo X, Pereiro Jr M, Guarro J. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 2000; 46: 390-394.
21. Guarro J, Pujol I, Aguilar C, Ortoneda M. In vitro antifungal susceptibility testing of nondermatophytic keratinophilic fungi. In: Kushwaha RKS, Guarro J (Eds.) Biology of dermatophytes and other keratinophilic fungi. Bilbao, Revista Iberoamericana de Micologia, 2000: 142-147.
22. Gugnani HC. Nondermatophytic filamentous keratinophilic fungi and their role in human. In: Kushwaha RKS, Guarro J (Eds.) Biology of dermatophytes and other keratinophilic fungi. Bilbao, Revista Iberoamericana de Micologia, 2000: 109-114.
23. Johnson EM, Szekely A, Warnock DW. In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens. Antimicrob Agents Chemother 1999; 43: 1260-1263.
24. Kappe R. Antifungal activity of the new azole UK-109, 496 (voriconazole). Mycoses 1999; 42 (Suppl 2): 83-86.
25. Larone DH. Medically important fungi. A guide to identification. Washington DC, AMS press, 1993.
26. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility of conidium-forming filamentous fungi. Proposed standard M28-A. Wayne, National Committee for Clinical Laboratory Standards, 2002.
27. Perea S, Fothergill AW, Sutton DA, Rinaldi MG. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J Clin Microbiol 2001; 39: 385-388.
28. Pujol I, Guarro J, Llop C, Soler L, Fernandez-Ballart J. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi. Antimicrob Agents Chemother 1996; 40: 2106-2110.
29. Ray MC, Gately LE. Dermatology manifestations of HIV infection in AIDS. Infect Dis Clin North Am 1994; 94: 583-605.
30. Ryder NS. Activity of terbinafine against serious fungal pathogens. Mycoses 1999; 42: 115-119.
31. Simpanya MF. Dermatophytes: their taxonomy, ecology and pathogenicity. In: Kushwaha RKS, Guarro J (Eds.) Biology of dermatophytes and other keratinophilic fungi. Bilbao, Revista Iberoamericana de Micología, 2000: 1-12.
32. Wildfeuer A, Seidl HP, Paule I, Haberreiter A. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 1998; 41: 309-319.